Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized phase 2 trial of cyclophosphamide + etoposide versus high-dose ifosfamide in relapsed osteosarcoma
2012-001010-42Phase 2Terminated
- Sponsor
- Italian Sarcoma Group
- Start
- Aug 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in osteosarcoma (OS) comparing Cyclophosphamide + etoposide with High-dose ifosfamide (2 arms). Primary endpoint: Overall response rate. Started Aug 2012; status: terminated.
02
Drugs
cyclophosphamideetoposideifosfamide
03
Conditions
osteosarcoma (OS)
Beyond the preview
Go deeper on 2012-001010-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-001010-42.